Sernova Biotherapeutics Statistics

Total Valuation

TSX:SVA has a market cap or net worth of CAD 54.20 million. The enterprise value is 56.94 million.

Market Cap	54.20M
Enterprise Value	56.94M

Important Dates

The last earnings date was Wednesday, June 11, 2025.

Earnings Date	Jun 11, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:SVA has 328.48 million shares outstanding. The number of shares has increased by 5.24% in one year.

Current Share Class	328.48M
Shares Outstanding	328.48M
Shares Change (YoY)	+5.24%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	4.09%
Owned by Institutions (%)	n/a
Float	315.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-2.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.59
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio	0.12
Quick Ratio	0.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.38

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-167.56%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	107.82%
Revenue Per Employee	n/a
Profits Per Employee	-1.37M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:SVA has paid 50,278 in taxes.

Income Tax	50,278
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.86% in the last 52 weeks. The beta is 0.90, so TSX:SVA's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-52.86%
50-Day Moving Average	0.19
200-Day Moving Average	0.21
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	129,350

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.96M
Pretax Income	-21.93M
Net Income	-21.98M
EBITDA	-20.67M
EBIT	-20.96M
Earnings Per Share (EPS)	-0.07

Full Income Statement

Balance Sheet

The company has 2.00 million in cash and 4.74 million in debt, giving a net cash position of -2.74 million or -0.01 per share.

Cash & Cash Equivalents	2.00M
Total Debt	4.74M
Net Cash	-2.74M
Net Cash Per Share	-0.01
Equity (Book Value)	-20.66M
Book Value Per Share	-0.07
Working Capital	-20.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-16.07M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:SVA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.24%
Shareholder Yield	-5.24%
Earnings Yield	-40.55%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1